Investigational Drug Information for KW-6356
What is the drug development status for KW-6356?
KW-6356 is an investigational drug.
There have been 8 clinical trials for KW-6356.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Parkinson Disease, Liver Diseases, and [disabled in preview]. The leading clinical trial sponsors are Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Co., Ltd, and Kyowa Kirin Pharmaceutical Development, Inc.
Summary for KW-6356
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2016-09-01) |
| Vendors | 21 |
Recent Clinical Trials for KW-6356
| Title | Sponsor | Phase |
|---|---|---|
| A Through QT/QTc Study of KW-6356 | Kyowa Kirin Co., Ltd. | Phase 1 |
| Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite | Kyowa Kirin Pharmaceutical Development, Inc. | Phase 1 |
| Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite | Kyowa Kirin, Inc. | Phase 1 |
Clinical Trial Summary for KW-6356
Top disease conditions for KW-6356
Top clinical trial sponsors for KW-6356
US Patents for KW-6356
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
